to 72 years (mean 53 years) and three men aged 60 to 71 years (mean 64 years). The duration of their systemic sclerosis ranged from six months to 20 years (mean 8-5 years). The overall disease was assessed as severe in six patients, moderately severe in nine, and mild in six. Small bowel structure was assessed by barium follow-through examination and in some cases by mucosal biopsy, and these changes were related to changes in small bowel function and the nutritional status of the patient. In addition, the relationship between small bowel involvement and other manifestations of the disease was examined.
METHODS
RADIOLOGICAL Barium meal and follow-through examinations were carried out using approximately 6 to 8 oz Micropaque. Radiographs were assessed without knowledge of the clinical severity of the disease or the results of the tests of small bowel function. All deviations from normal were noted. The diameters of the lumen of the duodenum, jejunum, and ileum were measured (Fig.  1) . The widest diameter of the duodenum was recorded. From a review of 50 random barium meals (Dawson, 1968 ) the upper limit of normal was taken to be 35 mm. For the jejunum, a mean of the three widest diameters was recorded, the upper limit of normal being taken as 30 mm (Laws, Shawdon, Booth, and Stewart, 1963) . For the ileum, an upper limit of 25 mm was accepted (Golden. 1965) . HAEMATOLOGICAL AND BIOCHEMICAL Haematological techniques were used as described by Dacie and Lewis (1963) .
Biochemical estimations were made according to Wootton (1964) . Serum vitamin B12 levels were estimated by microbiological assay using Eugena gracilis (Anderson, 1964) ; the normal range is 160 to 925 ,u,ug/ml. Serum folic acid levels were measured by microbiological assay using L casei. Control subjects have levels of more than 6 m,ug/ml (Waters and Mollins, 1961 Van de Kamer (1949) ; the normal is less than 5 g per day. Intestinal mucosal biopsies were obtained either from the duodenum or from the jejunum using a Crosby capsule (Crosby and Kugler, 1957) . Protein loss into the bowel was assessed in two patients using intra- (Table I) ; of these, three had clinically severe, four moderate, and one mild systemic sclerosis. Of four patients with mild radiological changes, two had moderate and two mild overall disease. Nine patients had no demonstrable small bowel involvement, and of these three each respectively had clinically severe, moderate, and mild systemic sclerosis.
The probable duration of systemic sclerosis in the eight patients with severe radiological changes averaged 7-6 years (range one to 17 years), in the four with mild radiological changes 9-8 years (range 0.5 to 15 years), and in the nine patients with no radiological changes 8-5 years (range one to 20 years).
NUTRITIONAL STATE Of the eight patients with severe radiological abnormalities only two (nos. 4 and 5) were below their ideal body weight (Table I) . Those patients with mild or absent radiological bowel involvement were within their ideal range of body weight.
The mean haemoglobin concentration in the eight patients with severe radiological small bowel involvement was 11-4 g (range 8 to 13 g); in the four with mild lesions it was 12.7g (range 11.6to 13.6g), and in those with no lesion, it was also 12.7 g (range 9.2 to 14-6 g); in those with severe involvement mean serum albumin concentration was 3.5 g (range 3.0 to 4 5 g); those with mild involvement had a mean value of 3-8 g (range 3-1 to 5.1 g), and in those with no involvement it was 4.0 g (range 3.3 to 5.2 g).
The patients with severe radiological small bowel lesions had a mean serum folate level of 4.0 m,ug (range 1.9 to 7-2 m,ug) and vitamin B12 level of 475 ,u,ug (range 210 to 960 ,u,g); those with mild lesions had a mean folate level of 5.0 m,ug (3-2 to 6.7 m,ug) and vitamin B12 level of 350 ,u,ug (180 to 525 ,u,g) (Table I) . Five out of the eight patients with severe radiological lesions had steatorrhoea.
A low rise of blood glucose after an oral load was found in two patients with severe lesions (nos. 1 and 5) and in two patients with no demonstrable lesions (nos. 13 and 16). Significantly low xylose excretion (< 3 g) was seen in two patients with severe lesions (nos. 4 and 6) and in one patient with no radiological change (no. 14). Impaired absorption of vitamin B12 + intrinsic factor was present in two patients (nos. 4 and 5), both with severe radiological changes.
ADDITIONAL DATA Raised levels of urinary indican were found in three patients (Table I ) with severe radiological changes (nos. 1, 4, and 5). Intubation was only performed in patient 5 and a significant growth (2 x 106) of E. coli cultured from her duodenal aspirate.
Raised Figlu excretion following a histidine load was found in 12 patients (four with severe, two with mild, and six with no bowel lesions); there was no relationship between serum folate levels and urinary excretion of Figlu.
Peroral mucosal biopsy was performed in 11 patients (five with radiological abnormalities), from the duodenum in seven, and jejunum in four, and was always normal.
There were no abnormalities of liver function; results of bromsulphalein excretion are shown in Table I .
CORRELATION OF SMALL BOWEL INVOLVEMENT WITH
OTHER FEATURES OF THE DISEASE Figure 6 shows the incidence of other manifestations of systemic sclerosis in the 12 patients of the current study with small bowel abnormalities compared with 14 patients (nine from the current study and five from our records) with definite systemic sclerosis but normal barium meal and follow-through radiographs. Both groups were of similar duration of disease and contained patients with gross, moderate, and mild skin sclerosis. Telangiectasia, calcinosis, and Raynaud's phenomenon, with a prolonged reactive hyperaemia, were of similar incidence, as was other systemic involvement. Oesophageal involvement, however, was seen more frequently (92 %) in patients with small bowel abnormalities compared to those without (42 %). One patient had severe small bowel disease without obvious oesophageal abnormality on x-ray examination. A positive L.E. cell test and the presence of antinuclear factor was of equal incidence in both groups (about 15 % and 80 % respectively (Sommerville et al, 1959; Heinz et al, 1963; Sackner, 1966 Laws, Shawdon, Booth, and Stewart (1963) . Thus diameters well above 30 mm, as in most of our cases, were undoubtedly abnormal. Dilatation of parts of the jejunum and duodenum was common and in some cases marked (Figs. 2, 3, and 4) .
Many patients had thickened folds, some with 'wire spring' appearances (simulating lymphangectasia) and pseudo-diverticula (Figs. 4 and 5) . No stenoses were seen in our series despite previous reports (Sacknei, 1966) , and only local abnormalities of motility were seen on screening. As previously noted by Reinhardt and Barry (1962) , flocculation of barium was common. We found little correlation between transit time and degree of involvement.
Six of the 12 patients with radiological involvement had steatorrhoea. In one it was severe but in the other five faecal fat was less than 10 g/day. There have been many case reports of severe steatorrhoea in systemic sclerosis (Kahn et al, 1965; Cliff et al, 1966; Salen et al, 1966; Greenberger et al, 1967 ) but we consider that more recognition should be given to the mild steatorrhoea commonly found and which requires no treatment.
Carbohydrate absorption was difficult to assess. Although abnormally low maximal rises in blood glucose after an oral glucose load was found in four patients, two with radiological involvement and two without, variation in the rate of stomach emptying affects glucose absorption. Xylose excretion is affected by renal function and there was evidence of renal impairment in two of the three patients (nos. 4 and 6) with low xylose excretion.
Vitamin B12 + intrinsic factor absorption was impaired in two patients (nos. 4 and 5), both of whom had evidence of small bowel bacterial colonization. However, both had normal serum B12 levels; both had had Schilling tests in the past.
Only the patient with severe steatorrhoea was obviously malnourished, and one other patient was also below his ideal body weight. However, there was a tendency for those patients with severe radiological small bowel involvement to have lower levels of haemoglobin, serum folate, and serum albumin.
In the series of 21 patients, 12 had raised excretion of Figlu in response to a histidine load; four of these had radiologically severe small bowel involvement. The reason for these alterations in histidine metabolism in systemic sclerosis is not clear, but this dissociation between serum folate levels and urinary excretion of Figlu has recently been described in rheumatoid arthritis by Omer and Mowat (1968) , who suggested that there may be deficiency of Figlu transferase, possibly related to activity of the disease.
The mechanism of the malabsorption complicating systemic sclerosis is not clear. Leneman et al (1962) discussed four possible mechanisms; they were bowel wall fibrosis, producing mechanical interference with peristalsis and poor mixing, blocked lymphatics, arteritis, and bacterial colonization.
Fibrosis of the muscular layers of the bowel wall producing disorder of motility and mixing is probably at least partly responsible for the malabsorption in our series, although this is difficult to prove functionally. Actual histological proof of fibrosis is difficult to obtain without laparotomy (we found that peroral mucosal biopsy did not show mucosal fibrosis or excess collagen around Brunner's glands as reported by Hoskins et al, 1962) , and although we were unable to obtain specimens on some of the patients with severe bowel lesions, we consider this investigation to be unhelpful in the recognition of small bowel involvement.
Fibrosis of the bowel wall might lead to lymphatic obstruction, and the radiological appearance like lymphangiectasia in six patients may be relevant; but in the two patients in whom gastrointestinal protein loss was assessed we were unable to demonstrate excessive loss into the bowel-a feature of the lymphatic obstruction of congenital lymphangiectasia. Thus the low serum albumin levels seen in some of our patients with small bowel involvement cannot be ascribed to this mechanism.
Although small artery occlusion is a manifestation of systemic sclerosis it does not appear to be any commoner, or more severe in those with small bowel lesions than those without. Thus there was an almost equal incidence and severity of digital artery occlusion, myopathy, and renal disease in both groups of patients (Fig. 6 ). In addition there were no symptoms suggestive of chronic ischaemia of the small bowel.
Bacterial colonization of the small bowel, producing steatorrhoea, is now a well documentated complication of systemic sclerosis (Kahn et al, 1965; Salen et al, 1966) . Wide, hypomotile loops of small bowel provide good sites for bacterial colonization. Four patients also had outpouching or pseudodiverticula, a feature previously noted by Heinz et al (1963) . In one patient there were definite diverticula and these may be a natural end stage of the small bowel involvement. Of the six patients with steatorrhoea, three had raised urinary indican excretion, suggesting small bowel bacterial colonization. Although in two the rise was only small and might perhaps be ascribed to creatorrhoea (Fordtran, Scroggie, and Polter, 1964) one of these (no. 5) had a significant growth of E. coli cultured from her duodenal juice and responded symptomatically to tetracycline.
It would appear that there are some patients with systemic sclerosis and small bowel involvement producing steatorrhoea in whom antibiotic therapy might be beneficial; three of our patients with steatorrhoea had evidence of bacterial colonization, but in the three others there was none.
It is not possible to predict which patients with systemic sclerosis are likely to have small bowel lesions. Gastrointestinal symptoms may be absent, and apart from frequent (92 %) accompanying oesophageal abnormality the incidence of other systemic involvement in groups with and without small bowel involvement was similar (Fig. 6) . Furthermore, even patients with minimal skin or other visceral sclerosis may have severe small bowel abnormalities (Orabona and Albano, 1958; Rodnan and Fennel, 1962) as an early manifestation of systemic sclerosis. Certainly in our series there was little correlation between small bowel involvement and overall severity or duration of systemic sclerosis. Barium follow-through examinations should be done in all patients with systemic sclerosis to detect the frequent small bowel involvement.
SUMMARY
The structure and function of the small bowel have been studied in 21 patients with systemic sclerosis. Twelve had radiological small bowel involvement; six of these had mild steatorrhoea and two impaired vitamin B12 absorption.
The diagnosis of small bowel involvement depends on radiological examination. Dilated loops of duodenum and jejunum are the striking abnormality and best detected by accurately measuring the diameter of the lumen. In addition we found thickened folds, 'pseudodiverticula', wire spring-like appearance, disordered motility, and flocculation.
Possible mechanisms for steatorrhoea in this disease are discussed. Small bowel bacterial colonization seemed a likely explanation in one patient and possible in two.
There was no correlation between duration, severity, or frequency of other organ involvement by systemic sclerosis and small bowel involvement, with the exception of almost invariable oesophageal abnormality in those patients with small bowel disease.
Systemic sclerosis affects the small bowel frequently and often early in the course of the disease; involvement is usually occult.
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